Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_provenance.
- NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_assertion description "[In this pilot investigation, we found an increased prevalence of the CYP2C8*4 mutation in the Type 2 diabetic patient group. This may result in a modification of drug degradation and drug efficacy in these patients and may have an influence, e.g. on the c]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_provenance.
- NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_assertion evidence source_evidence_literature NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_provenance.
- NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_assertion SIO_000772 20857895 NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_provenance.
- NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_assertion wasDerivedFrom gad-20150221 NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_provenance.
- NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_assertion wasGeneratedBy ECO_0000203 NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_provenance.
- gad-20150221 importedOn "2015-02-21" NP186402.RABzp1_MTVH_DbcplBX5YmNm2k0GViAEhDjcNGWsHezc8130_provenance.